Frontlight ResearchEarly access
Trial site
ICO - Centre René Gauducheau
- 7running trials
- 9closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Ovarian cancer8 trials
- Cervical cancer2 trials
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Neuroblastoma1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 26 trials
- Phase 35 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed9 trials
- Recruiting4 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- ARCAGY/ GINECO GROUP7 trials
- Grupo Español de Investigación en Cáncer de Ovario2 trials
- Centre Leon Berard1 trial
- Fondation Franc.Cancerologie Digestive1 trial
- Gustave Roussy, Cancer Campus, Grand Paris1 trial
- and 4 more
Running trials
Not yet recruiting
Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer
Recruiting
Active, not recruiting
Recruiting
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer3 recruiting
- Childhood cancers1 recruiting
- Lung cancer1 recruiting
- Neuroblastoma1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel
Completed
Completed
Completed
Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026